Long horizon capital AVP is an evergreen venture firm offering patient, long-duration capital to disruptive tech, typically investing at Series A to C with checks of 10M to 25M. This suggests an opportunity to discuss multi-year funding rounds, follow-on capacity, and strategic support for portfolio companies seeking stability and growth.

Portfolio growth leverage Recent investments across health tech, fertility AI, automation software, and care delivery indicate AVP prioritizes tech-enabled industries with large end markets. SDRs can position platform and value-add capabilities to scale portfolio companies, especially in AI, healthcare IT, and automation.

Strategic partnerships AVP campaigns alongside notable co-investors and a family-owned parent with cross-portfolio synergies present a channel for co-led rounds, syndicated investments, and collaboration on go-to-market initiatives, enterprise sales, and ecosystem development.

Tech stack familiarity AVP's tech ecosystem includes Microsoft Azure, Office 365, Clari, and data/ops tools like Isotope and Slick. This signals alignment opportunities for enterprise-grade solutions, CRM enablement, analytics, and cloud-based scaling services for portfolio companies.

Growth signals Multiple 2024–2026 funding announcements from AVP across diverse sectors demonstrate active deal velocity and a commitment to scaling, presenting a steady pipeline for BD outreach around Series A extensions, growth stage rounds, and strategic buy-side/partnering conversations.